Securities-Fraud Suits Backed by Supreme Court in Amgen Case

Securities-Fraud Suits Backed by Supreme Court in Amgen Case

Andrew Harrer/Bloomberg

The ruling is a defeat for business groups, including the U.S. Chamber of Commerce. They say class action cases are so expensive that companies are pressured to pay settlements regardless of the merits of the suit itself.